Survey: COVID-19 Test Kit Supply Needs to Triple Before Elective Surgeries Can Restart
COVID-19 testing capabilities would have to increase by at least 211% in order for hospitals and other healthcare facilities to resume providing elective procedures and diagnostic services.
Hospitals will need to be able to do the things they normally did before the COVID-19 pandemic struck in order for reopening plans in the United States to go smoothly-things like elective surgeries, many experts believe. But a new survey by the healthcare consulting company Premiere indicates that the shortage of COVID-19 test kits might make the old normal for hospitals tough to bring back.
Hospitals and other healthcare facilities need to increase their COVID-19 testing capabilities by at least 211% in order for them to resume providing elective procedures and diagnostic services. The data were collected from April 27 to April 30 from 150 hospitals, integrated delivery networks, and ambulatory surgery centers.
Michael J. Alkire, Premiere’s president, said in a press release that “current restrictions on capacity and shortages of swabs and reagents force health systems to limit testing, prioritizing patients and frontline workers who are symptomatic. Even with these strict conservation protocols, capacity needs to at least triple before enough is available to support even a partial restoration of non-emergency services.”
Eighty percent of the respondents said that they would like to increase their ability to conduct on-site COVID-19 testing, but many noted shortages of chemical reagents (41%) and viral swabs (40%) that are needed to perform the COVID-19 tests. In addition, only 32% of respondents said that they would be able to test all frontline healthcare workers. Regarding the testing of ancillary workers such as environmental services staff, only 22% of respondents said they could manage that.
Eighty-seven percent of respondents said that they intend to test patients admitted for an elective procedure for COVID-19; only 27% said they could test patients who want a diagnostic service. Meanwhile, 54% said that they will continue to bar visitors to conserve on COVID-19 tests.
“This represents a major challenge to patient care, as an inability to offer elective procedures and diagnostics can mean a missed opportunity to detect preventable illnesses early or begin treatments that are necessary for health and wellness,” Alkire said in the press release. He added: “Without adequate supplies, health systems are having to make hard choices to be as judicious as possible with their COVID-19 testing capacity. To reach an ideal state where testing is available for all healthcare workers, patients and caregivers, capacity will need to vastly expand.
Healing With Algorithms: AI's Impact on Epidemiology and Infection Control
April 2nd 2024Media in the US presents AI as both beneficial and risky. Positive coverage shows AI's potential through virtual assistants like Siri, while cautionary tales warn of misuse like misinformation and deepfakes. How does all this work in health care?
Four Years After COVID-19: What Has the Infection Prevention Community Learned?
March 15th 2024Four years ago today, March 15, 2020, the COVID-19 lockdown began, and since then, the world has undergone significant changes. It has been a terrifying experience for everyone, especially for the infection prevention community, both within and outside of the health care sector. However, a crucial question remains unanswered: What has the infection prevention community learned from this pandemic, and where does it go from here?
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
